Acute myelogenous leukemia.
Aquino
Victor M
VM
Department of Pediatrics, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D003582:Cytogenetics; D018572:Disease-Free Survival; D004314:Down Syndrome / Q000150:complications; D005544:Forecasting; D006801:Humans; D016130:Immunophenotyping; D007223:Infant; D007231:Infant, Newborn; D015470:Leukemia, Myeloid, Acute / Q000145:classification / Q000175:diagnosis / Q000235:genetics / Q000401:mortality / Q000628:therapy; D015473:Leukemia, Promyelocytic, Acute / Q000628:therapy; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012074:Remission Induction; D012307:Risk Factors; D013997:Time Factors; D015275:Tumor Lysis Syndrome
D000970:Antineoplastic Agents